Biomarker for diagnosis and prognosis of Multiple Sclerosis (MS)

Patent number:

EP24382907

No items found.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, UNIVERSIDAD AUTONOMA DE MADRID, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Novel biomarker for diagnosis and prognosis - Minimally invasive method through blood or CFS extraction - Known molecular mechanism of action - Novel pre-clinical model for MS

Comments

Other related patents

Health

NEW THERAPEUTIC TARGET FOR THE TREATMENT OF MYOTONIC DYSTROPHY

Countries

Spain

Health

TIAZOLIDINEDIONAS PARA USO EN LA PREVENCIÓN O EL TRATAMIENTO DE CRECIMIENTO ÓSEO ANORMAL

Countries

Spain

Health

Chemicals

" Procedure for producing a regioisomeric mixture of two derivatives of (11R, 17R) -11-epi-fistularin-3, inhibitory mixture of human leukemia cells "

Countries

Spain

Get back to patents directory